← Leaderboards
Melanie E Bennett
University Of Maryland Baltimore
$13,032,333
Attributed
$14,744,419
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,011,570 · 11
VA$0 · 1
By mechanism
R01$8,904,850 · 2
P01$6,534,302 · 4
R34$2,126,918 · 4
R21$445,500 · 1
I01$0 · 1
Top collaborators
- Bankole A Johnson3 shared
- Monica E Calkins2 shared
- Daniel Roche2 shared
- Faith Dickerson1 shared
- Amanda L Graham1 shared
- Seth S Himelhoch1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- L. Elliot Hong$24,654,132
- William T. Carpenter$18,855,146
- James M. Gold$25,110,473
- Robert W Buchanan$22,479,930
- A Lahti$703,346
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsTrainingMental HealthServicesParticipantLearningSymptomsRecoveryMonitorBaseCommunitiesDesignResearch Project GrantsEvidence BaseCaringSchizophreniaEffective TherapySiteFeedbackFirst Episode PsychosisFamily MemberResponseHigh RiskFollow-Up
Grant awards (36)
Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC$1,560,928
P01 · FY2025 · MH · contact PI
UMB Admin Core$926,825
P01 · FY2025 · MH · contact PI
Project 2$392,582
P01 · FY2025 · MH · contact PI
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting$301,281
R34 · FY2025 · AA · contact PI
Project 1$241,521
P01 · FY2025 · MH · contact PI
Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC$1,706,223
P01 · FY2024 · MH · contact PI
UMB Admin Core$1,095,285
P01 · FY2024 · MH · contact PI
Project 2$355,396
P01 · FY2024 · MH · contact PI
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting$301,281
R34 · FY2024 · AA · contact PI
Project 1$255,542
P01 · FY2024 · MH · contact PI
Connecting FEP Research and Practice through a Learning Health System$1,308,610
R01 · FY2023 · MH · contact PI
Connecting FEP Research and Practice through a Learning Health System$1,357,851
R01 · FY2022 · MH · contact PI
Improving Engagement in Black Clients Participating in Coordinated Specialty Care: A Mixed Methods Pilot Study$178,784
R01 · FY2022 · MH · contact PI
Connecting FEP Research and Practice through a Learning Health System$175,640
R01 · FY2022 · MH · contact PI
Connecting FEP Research and Practice through a Learning Health System$1,374,266
R01 · FY2021 · MH · contact PI
Connecting FEP Research and Practice through a Learning Health System$1,489,361
R01 · FY2020 · MH · contact PI
Adapting a Digital Intervention to Improve Smoking Cessation in Persons with Serious Mental Illness$666,315
R34 · FY2020 · MH · contact PI
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$559,085
R01 · FY2020 · AA · contact PI
Impact of the COVID-19 Pandemic on Alcohol Use and PTSD Symptoms in a Sample of African American Heavy Drinkers$152,703
R01 · FY2020 · AA · contact PI
Improving Negative Symptoms & Community Engagement in Veterans with Schizophrenia$0
I01 · FY2020 · VA · contact PI
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$588,959
R01 · FY2019 · AA · contact PI
Improving Negative Symptoms & Community Engagement in Veterans with Schizophrenia$0
I01 · FY2019 · VA · contact PI
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$598,446
R01 · FY2018 · AA
Improving Negative Symptoms & Community Engagement in Veterans with Schizophrenia$0
I01 · FY2018 · VA · contact PI
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$552,743
R01 · FY2017 · AA
Improving Negative Symptoms & Community Engagement in Veterans with Schizophrenia$0
I01 · FY2017 · VA · contact PI
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$568,402
R01 · FY2016 · AA
Improving Negative Symptoms & Community Engagement in Veterans with Schizophrenia$0
I01 · FY2016 · VA · contact PI
Improving Negative Symptoms & Community Engagement in Veterans with Schizophrenia$0
I01 · FY2015 · VA · contact PI
Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention$213,600
R34 · FY2013 · MH · contact PI
An Integrated Approach to Smoking Cessation in SMI$214,624
R34 · FY2010 · MH · contact PI
An Integrated Approach to Smoking Cessation in SMI$215,681
R34 · FY2009 · MH · contact PI
An Integrated Approach to Smoking Cessation in SMI$214,136
R34 · FY2008 · MH · contact PI
Treatment of Alcohol Use Disorders in Schizophrenia$148,500
R21 · FY2005 · AA
Treatment of Alcohol Use Disorders in Schizophrenia$148,500
R21 · FY2004 · AA
Treatment of Alcohol Use Disorders in Schizophrenia$148,500
R21 · FY2003 · AA